Epigenomics AG / Key word(s): Product Launch/Study 15.05.2013 / 09:00 Results of Comparative Study between Epigenomics Epi proColon(R) and FIT to be Presented at Digestive Disease Week Berlin, Germany, and U.S.A., May 15, 2013 – Epigenomics AG (Frankfurt Prime Standard: ECX), the German-American cancer molecular diagnostics company, today announced that results of the head-to-head comparative […]
Year: 2013
15. May 2013
Epigenomics AG: Results of Comparative Study between Epigenomics Epi proColon(R) and FIT to be Presented at Digestive Disease Week
Read more
08. May 2013
Epigenomics AG: Epigenomics AG Announces Q1 2013 Financial Results and Reports on Operational Highlights
Epigenomics AG / Key word(s): Quarter Results 08.05.2013 / 08:30 Epigenomics AG Announces Q1 2013 Financial Results and Reports on Operational Highlights Berlin, Germany, and, U.S.A., May 8, 2013 – Epigenomics AG (Frankfurt Prime Standard: ECX), the German-American cancer molecular diagnostics company, today announced its financial results for the first quarter ending March 31, 2013. […]